Publications

Title

Author

Year

Assessing the impacts of timing on the health benefits, cost-effectiveness and relative affordability of COVID-19 vaccination programmes in 27 African Countries.

LIU, Y; PEARSON, CA B; Madriz Montero, A; TORRES-RUEDA, S; Asfaw, E; Uzochukwu, B; Drake, T; Bergren, E; EGGO, R; RUIZ, F; Ndembi, N; Nonvignon, J; JIT, M; VASSALL, A;

2022

medRxiv (2022). 10.1101/2022.05.09.22274846.

ISIDLSHTM/Model_Size_Selection.

BENEST, J; Rhodes, S; Evans, TG; WHITE, RG;

2022

, Github (2022).

Safety and Immunogenicity of a Two-Dose AD26.ZEBOV, MVA-BN-FILO EBOLA Vaccine Regimen in Infants: A Randomised, Double-Blind, Controlled Trial in Sierra Leone and Guinea. (Abstract, Presentation ref ID951).

CHOI, E; Baiden, F; AFOLABI, M; Foster, J; MANNO, D; Ishola, D; Njie, Y; Lowe, B; Lawal, B; Otieno, GT; GREENWOOD, B; WATSON-JONES, D;

2022

(2022).

Live-attenuated influenza vaccine effectiveness against hospitalization in children aged 2-6 years, the first three seasons of the childhood influenza vaccination program in England, 2013/14-2015/16.

Boddington, NL; MANGTANI, P; Zhao, H; Verlander, NQ; Ellis, J; Andrews, N; Pebody, RG;

2022

Influenza and Other Respiratory Viruses, (2022).16 5 10.1111/irv.12990.

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: a modelling study.

Portnoy, A; Clark, R; Quaife, M; WEERASURIYA, C; Mukandavire, C; Bakker, R; Deol, A; Malhotra, S; Gebreselassie, N; Zignol, M; Sim, SY; Hutubessy, RC W; Baena, IG; Nishikiori, N; JIT, M; WHITE, R; Menzies, N;

2022

medRxiv (2022). 10.1101/2022.05.04.22274654.

Now or later: Health impacts of delaying single-dose HPV vaccine implementation in a high-burden setting.

Burger, EA; Laprise, J-F; Sy, S; Regan, MC; PREM, K; JIT, M; Brisson, M; Kim, JJ;

2022

International Journal of Cancer, (2022).151 10 10.1002/ijc.34054.

Correction: COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness.

PEARSON, CA B; BOZZANI, F; PROCTER, SR; DAVIES, NG; Huda, M; JENSEN, HT; KEOGH-BROWN, M; Khalid, M; SWEENEY, S; TORRES-RUEDA, S; CHiL COVID-19 Working Group,; CMMID COVID-19 Working Group,; EGGO, RM; VASSALL, A; JIT, M;

2022

PLoS medicine, (2022).19 5 10.1371/journal.pmed.1003990.

Development of an educational package for the universal human papillomavirus (HPV) vaccination programme: a co-production study with young people and key informants.

Fisher, H; CHANTLER, T; Finn, A; Kesten, J; Hickman, M; Letley, L; MOUNIER-JACK, S; Thomas, C; Worthington, K; Yates, J; Audrey, S;

2022

Research involvement and engagement, (2022).8 1 10.1186/s40900-022-00349-7.

Updating age-specific contact structures to match evolving demography in a dynamic mathematical model of tuberculosis vaccination.

WEERASURIYA, CK; Harris, RC; MCQUAID, CF; Gomez, GB; WHITE, RG;

2022

PLoS Computational Biology, (2022).18 4 10.1371/journal.pcbi.1010002.

Engineering a suite of E. coli strains for enhanced expression of bacterial polysaccharides and glycoconjugate vaccines.

KAY, EJ; MAURI, M; WILLCOCKS, SJ; SCOTT, TA; CUCCUI, J; WREN, BW;